| |
| |
|
| Insider
Information: |
Zorn Peter A |
| Relationship: |
Senior VP, Corp Dev, G... |
| City: |
Winston-Salem |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
934 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$41,236 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
934 |
|
|
| Total
Value |
$41,236 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gyre Therapeutics |
GYRE |
SVP, Lg Affrs, GC and ... |
2010-03-31 |
0 |
2009-10-19 |
0 |
Premium* |
|
|
Albireo Pharma Inc |
ALBO |
Senior VP, Corp Dev, G... |
2016-11-03 |
934 |
2016-11-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALBO |
Albireo Pharma Inc |
Senior VP, Corp Dev, GC & Sec |
• – – |
2016-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
934 |
934 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Lg Affrs, GC and Secrtary |
• – – |
2010-03-31 |
4 |
S |
$19.41 |
$6,075 |
D/D |
(313) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Lg Affrs, GC and Secrtary |
• – – |
2010-03-31 |
4 |
OE |
$5.10 |
$1,596 |
D/D |
313 |
313 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Lg Affrs, GC and Secrtary |
• – – |
2009-12-31 |
4 |
S |
$21.02 |
$92,663 |
D/D |
(4,404) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Lg Affrs, GC and Secrtary |
• – – |
2009-12-31 |
4 |
OE |
$5.10 |
$24,302 |
D/D |
4,404 |
4,092 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Lg Affrs, GC and Secrtary |
• – – |
2009-10-22 |
4 |
S |
$20.64 |
$124,585 |
D/D |
(6,035) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Lg Affrs, GC and Secrtary |
• – – |
2009-10-22 |
4 |
OE |
$5.55 |
$33,494 |
D/D |
6,035 |
6,035 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Lg Affrs, GC and Secrtary |
• – – |
2009-10-21 |
4 |
S |
$21.00 |
$1,930,308 |
D/D |
(91,898) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Lg Affrs, GC and Secrtary |
• – – |
2009-10-21 |
4 |
OE |
$1.75 |
$361,481 |
D/D |
91,898 |
91,898 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Lg Affrs, GC and Secrtary |
• – – |
2009-10-20 |
4 |
S |
$21.40 |
$506,148 |
D/D |
(23,650) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Lg Affrs, GC and Secrtary |
• – – |
2009-10-20 |
4 |
OE |
$1.75 |
$58,205 |
D/D |
23,650 |
23,650 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Lg Affrs, GC and Secrtary |
• – – |
2009-10-19 |
4 |
S |
$22.68 |
$131,515 |
D/D |
(5,800) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Lg Affrs, GC and Secrtary |
• – – |
2009-10-19 |
4 |
OE |
$5.10 |
$29,580 |
D/D |
5,800 |
5,800 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
